#Latest news with #regulatory approvalBloomberg2 days agoHealthBloombergFDA Says Sarepta Can Treat Ambulatory Patients With Gene TherapyIn a major win for Sarepta Therapeutics Inc., US regulators are recommending that patients who can walk be allowed to take its gene therapy Elevidys again. In a statement Monday, the regulator said that it had concluded that the death of an 8-year-old in Brazil was not related to the therapy.
Bloomberg2 days agoHealthBloombergFDA Says Sarepta Can Treat Ambulatory Patients With Gene TherapyIn a major win for Sarepta Therapeutics Inc., US regulators are recommending that patients who can walk be allowed to take its gene therapy Elevidys again. In a statement Monday, the regulator said that it had concluded that the death of an 8-year-old in Brazil was not related to the therapy.
2 days ago
